TWINSTRAND BIOSCIENCES INC
Ultra-rare variant detection with unparalleled sensitivity
SEATTLE, United States · Founded 2017 · $66.0M raised
- Headquarters
- SEATTLE, Washington
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- twinstrandbio.com
- Total Funding
- $66.0M
- Last Round
- $50.0M Series BMay 2021
- Rounds
- 2
About
TwinStrand Biosciences develops and commercializes Duplex Sequencing technology, which improves DNA sequencing accuracy by over 10,000-fold to detect ultra-low frequency mutations invisible by conventional NGS methods. The company serves pharmaceutical companies, clinical research networks, academic centers, and regulatory agencies across applications including residual cancer detection, genetic toxicology, and mutagenesis assay testing.
Summary
TWINSTRAND BIOSCIENCES INC is a Biotech company based in SEATTLE, United States, founded in 2017. It has raised $66.0M in total across 2 rounds, most recently a $50.0M Series B round in May 2021. Investors include Madrona Venture, S32 and Soleus Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...